Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kneba, Michael
108  Ergebnisse:
Personensuche X
?
1

Bendamustine, followed by obinutuzumab and idelalisib in ch..:

Cramer, Paula ; von Tresckow, Julia ; Fink, Anna‐Maria...
American Journal of Hematology.  99 (2024)  6 - p. 1192-1195 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Patient specific real-time PCR in precision medicine – Vali..:

Schilhabel, Anke ; Szczepanowski, Monika ; van Gastel-Mol, Ellen J....
Frontiers in Oncology.  12 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

CD20 Expression as a Possible Novel Prognostic Marker in CL..:

Schilhabel, Anke ; Walter, Peter Jonas ; Cramer, Paula...
Cancers.  14 (2022)  19 - p. 4917 , 2022
Link: https://doi.org/10.3390/..
 
?
4

Long Term Follow‐up Data and Health‐Related Quality of Life..:

Kutsch, Nadine ; Bahlo, Jasmin ; Robrecht, Sandra...
HemaSphere.  4 (2020)  1 - p. , 2020
Link: https://doi.org/10.1097/..
 
?
5

Early treatment with FCR versus watch and wait in patients ..:

Herling, Carmen D. ; Cymbalista, Florence ; Groß-Ophoff-Müller, Carolin...
Leukemia.  34 (2020)  8 - p. 2038-2050 , 2020
Link: https://doi.org/10.1038/..
 
?
6

Influence of obesity and gender on treatment outcomes in pa..:

Fürstenau, Moritz ; Hopfinger, Georg ; Robrecht, Sandra...
Leukemia.  34 (2019)  4 - p. 1177-1181 , 2019
Link: https://doi.org/10.1038/..
 
?
7

Four versus six cycles of CHOP chemotherapy in combination ..:

Poeschel, Viola ; Held, Gerhard ; Ziepert, Marita...
The Lancet.  394 (2019)  10216 - p. 2271-2281 , 2019
Link: https://doi.org/10.1016/..
 
?
8

Short telomeres are associated with inferior outcome, genom..:

Jebaraj, Billy Michael Chelliah ; Tausch, Eugen ; Landau, Dan A....
Leukemia.  33 (2019)  9 - p. 2183-2194 , 2019
Link: https://doi.org/10.1038/..
 
?
9

Defining therapy goals for major molecular remission in chr..:

Saussele, Susanne ; Hehlmann, Rüdiger ; Fabarius, Alice...
Leukemia.  32 (2018)  5 - p. 1222-1228 , 2018
Link: https://doi.org/10.1038/..
 
?
10

Is Next-Generation Sequencing the way to go for Residual Di..:

Kotrova, Michaela ; Trka, Jan ; Kneba, Michael.
Molecular Diagnosis & Therapy.  21 (2017)  5 - p. 481-492 , 2017
Link: https://doi.org/10.1007/..
 
?
11

Addition of high-dose cytarabine to immunochemotherapy befo..:

Hermine, Olivier ; Hoster, Eva ; Walewski, Jan...
The Lancet.  388 (2016)  10044 - p. 565-575 , 2016
Link: https://doi.org/10.1016/..
 
?
12

Impact of telomere length on the outcome of allogeneic stem..:

Scheffold, Annika ; Jebaraj, Billy Michael Chelliah ; Jaramillo, Sonia...
British Journal of Haematology.  179 (2016)  2 - p. 342-346 , 2016
Link: https://doi.org/10.1111/..
 
?
13

Alemtuzumab consolidation in chronic lymphocytic leukaemia:..:

Al‐Sawaf, Othman ; Fischer, Kirsten ; Herling, Carmen D....
European Journal of Haematology.  98 (2016)  3 - p. 254-262 , 2016
Link: https://doi.org/10.1111/..
 
?
14

Bendamustine and rituximab in combination with lenalidomide..:

Maurer, Christian ; Pflug, Natali ; Bahlo, Jasmin...
European Journal of Haematology.  97 (2016)  3 - p. 253-260 , 2016
Link: https://doi.org/10.1111/..
 
?
15

Mutations driving CLL and their evolution in progression an..:

Landau, Dan A. ; Tausch, Eugen ; Taylor-Weiner, Amaro N....
Nature.  526 (2015)  7574 - p. 525-530 , 2015
Link: https://doi.org/10.1038/..
 
1-15